New Analysis Published in Peer-reviewed Psychiatry Research Shows Advantages of Combinatorial Algorithm of GeneSight® Psychotropic Test
Does that match what you're seeing?
GeneSight is a pharmacogenomic test by Myriad Genetics that analyzes a patient's DNA to determine how their genes may affect their response to psychiatric and neurological medications, helping clinicians select more effective antidepressants, antipsychotics, and other psychotropic drugs while avoiding medications likely to cause adverse effects.
GeneSight Intelligence Room
See. Share. Shape.
Every post on social media is buried the next day. Not here. Signals become memory, and memory becomes intelligence.
Share your experience about GeneSight
Trending signal
Human reality
What users are seeing.
Gathering
The first real accounts of GeneSight are still being gathered.
Tool intelligence
What HealthAratus understands
HealthAratus currently understands GeneSight through company records and external market activity.
- Category
- imaging_diagnostics
What HealthAratus is still learning
HealthAratus is beginning to understand GeneSight. As evidence and experience accumulate, what remains unclear will be stated here.
Category ranking
Imaging & Diagnostics
260+ tools observed
- 81KyruusstableDeveloping
- 82QventussurgingDeveloping
- 83HealthifystableDeveloping
- 84GeneSightstableDeveloping
- 85BaxterstableDeveloping
- 86Boston ScientificsurgingDeveloping
- 87ZiplinestableDeveloping
GeneSight is ranked number 84 in Imaging & Diagnostics by HealthAratus Score). Rankings will change as more intelligence comes in, so follow GeneSight to see all changes.
See. Share. Shape.